Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Kapoor, R.R.; James, C.; Flanagan, S.E.; Ellard, S.; Eaton, S.; Hussain, K.
    3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity (2009), J. Clin. Endocrinol. Metab., 94, 2221-2225.
    View publication on PubMed

Application

EC Number Application Comment Organism
1.1.1.35 medicine HADH protects against excess amino acid-induced insulin secretion Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
1.1.1.35 Homo sapiens
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
1.1.1.35 leukocyte
-
 Homo sapiens
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
1.1.1.35 3-oxohexadecanoyl-CoA + NADH + H+
-
 Homo sapiens (S)-3-hydroxhexadecanoyl-CoA + NAD+
-
 ?
1.1.1.35 3-oxooctanoyl-CoA + NADH + H+
-
 Homo sapiens (S)-3-hydroxyoctanoyl-CoA + NAD+
-
 ?
1.1.1.35 acetoacetyl-CoA + NADH + H+
-
 Homo sapiens 3-hydroxybutyryl-CoA + NAD+
-
 ?
1.1.1.35 additional information HADH gene with a novel homozygous missense mutation M188V. Mutations in the HADH gene are associated with significantly decreased short-chain L-HADH activity, mildly decreased medium- and long-chain L-HADH activity, protein-induced hyperinsulinemic hypoglycemia. Patients with hyperinsulinemic hypoglycemia due to HADH gene mutations may have normal acylcarnitines and urine organic acids Homo sapiens ?
-
 ?

Synonyms

EC Number Synonyms Comment Organism
1.1.1.35 3-hydroxyacyl-coenzyme A dehydrogenase
-
 Homo sapiens
1.1.1.35 HADH
-
 Homo sapiens